XTL BIOPHARMACEUTICALS LTD. Profit Loss From Discontinued Operations
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Profit Loss From Discontinued Operations of -$689.00 thousand for the 12-month period ending 2015-12-31, per its 20-F filed 2018-03-15.
Discontinued › Notes
ifrs-full:ProfitLossFromDiscontinuedOperations · last filed 2018-03-15
| Period end | Profit Loss From Discontinued Operations 12 month |
|---|---|
| 2015-12-31 | -$689.00K 20-F · filed 2018-03-15 |